Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA requests recall of two men’s energy supplements

This article was originally published in The Tan Sheet

Executive Summary

FDA requests a recall of True Man Sexual Energy Nutrient Capsules and Energy Max Energy Supplement Men's Formula Capsules because they contain potentially harmful and undeclared ingredients, the agency announces Nov. 2. The products are advertised as being "all natural" alternatives to FDA-approved erectile dysfunction drugs, but could interact with medications and cause low blood pressure because True Man and Energy Max contain analogs of sildenafil and vardenafil, the active ingredients in Pfizer's Viagra and GlaxoSmithKiline's/Schering-Plough's Levitra, respectively. FDA repeatedly has said its plans to ramp up enforcement against companies using drug ingredients in supplements (1"The Tan Sheet" Oct. 15, 2007, p. 3)...

You may also be interested in...



FDA Plans To Step Up Enforcement Actions On Supplement Rx Contaminants

FDA anticipates media coverage of its enforcement actions against firms marketing illegal supplement products will benefit responsible members of the industry, according to Center for Food Safety and Applied Nutrition Director Robert E. Brackett

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

Topics

UsernamePublicRestriction

Register

PS101089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel